Project ALS
Non-Profit & Charitable Organizations · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2585 Broadway Ste 202, New York City, Ne...Phone Number
(212) 420-7382Website
www.projectals.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Project ALS
Project ALS is dedicated to advancing research in amyotrophic lateral sclerosis (ALS) through community support and innovative initiatives. They offer ongoing updates and information on ALS research, as well as opportunities for the public to stay involved. The organization has garnered support through campaigns like Thank You! Stars For Sarah, which highlights their commitment to fighting ALS. Their intended clients include individuals affected by ALS, researchers, and community members interested in contributing to ALS research.Explore more
Project ALS Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Project ALS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Project ALS has new funding data
Earning: See what the market has to say on Project ALS recently announced quarterly report
Click to see if Project ALS had a recent Job posting/layoffs
Check if Project ALS has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Project ALS, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Project ALS is spiking on competitors!
Product Launch: Get notified when Project ALS launches new products
Congratulate Masked Content for being promoted to Masked Content at Project ALS
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Project ALS
Compare insights from companies similar to Project ALS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
<$5M
2007
GE
Glen EstrinPresident and Co-Founder, Leon Fleisher Foundation for Musicians With Dystonia Advisory Board
Company Profile Activity
Activity Insights
Project ALS is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Project ALS is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Project ALS.
Project ALS financials insights
Gather financial insights about Project ALS, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$102K
Project ALS Tech Stack
A closer look at the technologies used by Project ALS
Project ALS News & Media
ProJenX launches to advance novel, targeted therapies for ALS and other brain diseases
NEW YORK, Feb. 16, 2022 /PRNewswire/ -- ProJenX, a New York City-based, clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined pathways for the treatment of amyotrophic lateral sclerosis (ALS) and other debilitating brain diseases,...Project ALS Announces Research Advisory Board 2.0
NEW YORK, Oct. 20, 2021 /PRNewswire/ -- Project ALS, a non-profit 501(c)3 leader in the pursuit of treatments and a cure for the neurodegenerative disease ALS, has announced its research advisory board (RAB). Non-Profit ALS Research Leader Gathers a Diversity of Expertise to Guide...Project ALS Granted FDA Orphan Drug Designation for Prosetin for the Treatment of Amyotrophic Lateral Sclerosis
NEW YORK, Sept. 4, 2020 /PRNewswire/ -- Project ALS, a non-profit 501(c)3 organization that funds research toward the first meaningful treatments for amyotrophic lateral sclerosis (ALS), announced today that the Food and Drug Administration (FDA) has granted orphan drug designation to...Medidata Institute and Project ALS Launch Partnership to Accelerate New Treatment Strategies
NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company, and the global leader in creating end-to-end solutions supporting the entire clinical trial process, announced the launch of a research partnership between the Medidata Institute and Project ALS. The program is designed to gain a greater understanding of the ALS disease process and develop new therapeutic strategies. The Medidata Institute engages and partners with research organizations, life science companies, researchers, regu
Read more news
Top Non-Profit & Charitable Organizations Companies
Frequently Asked Questions Regarding Project ALS
Sign Up For FreeTo access detailed company insights
Project ALS is dedicated to advancing research in amyotrophic lateral sclerosis (ALS) through community support and innovative initiatives. They offer ongoing updates and information on ALS research, as well as opportunities for the public to stay involved. The organization has garnered support through campaigns like Thank You! Stars For Sarah, whi... Read More
